SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-181293
Filing Date
2023-07-03
Accepted
2023-07-03 15:14:00
Documents
12
Period of Report
2023-06-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d530995d8k.htm   iXBRL 8-K 21846
  Complete submission text file 0001193125-23-181293.txt   143028

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20230626.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20230626_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20230626_pre.xml EX-101.PRE 11277
6 EXTRACTED XBRL INSTANCE DOCUMENT d530995d8k_htm.xml XML 3413
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 231065003
SIC: 2836 Biological Products, (No Diagnostic Substances)